Novoprotein Scientific Inc.
- Biotech or pharma, animal health
- CMO, CRO
- Other products or services
- Other R&D services
Novoprotein is out-licensing 50 lead-optimized, fully humanized antibody candidates. Targets include 4-1BB, AXL, Aβ, B7-H3, BAFF, BCMA, C5AR1, CCR7, CCR8, CD166, CD16A, CD3, CD33, CD38, CD40, CD47, CD73, CEACAM5, claudin18.2, CLDN6, CLDN9, Coagulation Factor III, CXCR5, DR5, ETAR, FPN1, GCGR, GIPR, GPRC5D, HER3, HGF, LILRB2, Napi2B, NKG2D, NRP1, OX40, PD-1, PD-L1, RSV, SCN9A, TFR, TIGIT, TROP-2, TSLP, and VEGF
Contact: Trung Nguyen, PhD, Director of Business Development – CRO Services & Licensing. Email: trungnguyen@novoprotein.com.cn Phone: 714-854-2459
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}